Compare IDEXX Laboratories, Inc. (IDXX) vs Main Street Capital Corporation (MAIN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Main Street Capital Corporation — how do they compare? IDEXX Laboratories, Inc. trades at $569.65 (market cap $46.22B), while Main Street Capital Corporation trades at $58.32 (market cap $5.52B). The key difference: IDEXX Laboratories, Inc. is far larger — about 8.4× Main Street Capital Corporation's market cap, and Main Street Capital Corporation pays a 5.39% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | MAIN | |
|---|---|---|
Market Cap | $46.22B | $5.52B |
Sector | Health | Financials |
52-Week High | $766.68 | $67.54 |
52-Week Low | $526.44 | $49.63 |
Enterprise Value | $47.12B | — |
Dividend Yield | — | 5.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $570.58, down 4.23% over 24 hours, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $4.27 surpassing the $3.94 expectation. Revenue growth remains robust, supported by a 74.21% ROE and expanding diagnostic offerings. Recent news highlights product expansion, including a dual-species cardiac test, reinforcing its market leadership in veterinary diagnostics.
The outlook is positive, driven by durable competitive advantages and international growth potential. However, elevated valuation multiples and competitive pressures pose risks. Analyst consensus is bullish with a $683.33 price target, suggesting significant upside from current levels, though investors should monitor execution on guidance and macroeconomic headwinds.
Main Street Capital (MAIN) trades at $58.51, slightly below the consensus price target of $56.67, with mixed technical signals showing bullish moving averages but overbought RSI levels. The company maintains strong profitability with an 80.77% net income margin and 14.92% ROE, though Q2 2026 earnings of $0.97 per share missed expectations. Recent dividend announcements and portfolio appreciation highlight MAIN's income-focused strategy in the BDC sector.
MAIN presents a stable income opportunity with consistent dividends, but faces headwinds from higher expenses impacting recent earnings. The stock's current valuation at 11.85x P/E appears reasonable, though investor caution is warranted given the majority hold rating from analysts and competitive pressures in the private credit market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Main Street Capital Corporation
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants and other securities of the lower middle market and middle market companies based in the US. Business is functioned through the U.S region and it derives the majority of the income from the source of fee, commission, and interest.
Read more on MAIN →
